Newer and better tests are coming. The STHLM3 prostate cancer screening test, compared with current clinical screening, significantly reduces the rate of unnecessary biopsies without compromising the identification of high-risk prostate cancer.
The STHLM3 test is now available in Sweden, and the researchers hope to expand it to other countries, including the United States, in the near future.
www.health.harvard.edu/mens-health/test-may-diagnose-prostate-cancer-more-accurately